ASCO Annual Meeting 2012 PHASE II STUDY OF PANITUMUMAB (P) IN COMBINATION WITH FOLFOXIRI AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC): HIGH ACTIVITY IN…
A Harborside Press Publication Editor-in-Chief, James O. Armitage, MD ASCOPost.com VOLUME 1, ISSUE 6 NOVEMBER 2010 continued on page 3 continued on page 6 MORE IN THIS ISSUE…